We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Highlights Diagnostic Technologies for Point-of-Care Testing Applications

By LabMedica International staff writers
Posted on 13 Nov 2023

EKF Diagnostics (Cardiff, Wales, UK) is showcasing its diagnostic technologies and biotechnology solutions at MEDICA 2023 that empower healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications. More...

EKF offers cutting-edge point-of-care diagnostic solutions that provide healthcare professionals and patients with rapid, accurate, and accessible testing capabilities and results. The company’s technologies allow for informed decision-making, timely interventions, and improved patient outcomes at the point of care. EKF leads in supporting life sciences applications and research through innovative biotechnology solutions. The company’s comprehensive portfolio offers powerful tools to researchers, scientists, and clinicians for accurate and reliable delivery and results, driving breakthrough discoveries and advancements in healthcare and medical understanding.

Visitors to the EKF booth can explore the company’s range of point-of-care medical diagnostic solutions for hematology and diabetes, including the DiaSpect Tm and Hemo Control hemoglobin analyzers, the Biosen C-Line glucose and lactate analyzer, and the Quo-Test and Quo-Lab HbA1c Analyzers. They can also discover more about EKF Link, the company’s optional software platform designed to provide a flexible and secure method for connecting point-of-care devices to hospital and laboratory IT systems. Additionally, visitors can learn more about EKF Life Sciences, and the company’s latest developments in microbial fermentation, custom bioprocessing, and contract manufacturing.

EKF’s DiaSpect Tm is a hand-held analyzer that provides immediate hemoglobin results and hematocrit calculation while the Hemo Control hemoglobin analyzer delivers accurate hemoglobin and hematocrit results with one simple test. Similarly, the Biosen C-Line Line glucose and lactate analyzer from EKF is designed for lab-accurate glucose and lactate measurement in one test. Among other products on display at MEDICA 2023 is the revolutionary Quo-Lab semi-automated analyzer for HbA1c measurement that provides affordable A1c testing with results in just four minutes. The Quo-Test fully automated analyzer on display at MEDICA 2023 is designed for fast, accurate, and reliable HbA1c measurement with results available in only four minutes.

Related Links:
EKF Diagnostics 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.